The Company has transferred the FDA-approved bone biomarker CTX-I and fibrogenesis biomarker PRO-C3 to the Roche COBAS ...

Check the time stamp on this data. Updated AI-Generated Signals for C3.ai Inc. Class A (AI) available here: AI.

Northland Capital has recently raised C3.ai Inc (AI) stock to Outperform rating, as announced on May 30, 2024, according to Finviz. Earlier, on November 21, 2023, Oppenheimer had raised the stock from ...

Nutanix (NTNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

The best home entertainment buying advice Issues delivered straight to your door or device It's a strange time for OLED TV ...

Notre Dame's soccer season ended with a 2-0 shutout loss to Farmington in the Class 3 District 1 final on Thursday night. Despite a rocky start, the Bulldogs clawed their way back to reach their 10th ...

Flex Power Modules introduces the BMR316, a high-performance non-isolated, unregulated DC/DC intermediate bus converter (IBC) ...

Shares of C3.ai Inc. AI shed 0.65% to $27.52 Thursday, on what proved to be an all-around mixed trading session for the stock ...

On Wednesday, C3.ai Inc (AI) stock saw a modest uptick, ending the day at $27.7 which represents a slight increase of $1.11 or 4.17% from the prior close of $26.59. The stock opened at $27.49 and ...

Revenue growth alone hasn't been enough to convince investors that C3.ai is a good stock to buy, and that may not change ...

C3.ai, Inc. (AI) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Research firm MarketsandMarkets valued the current retail artificial intelligence market at $31.12 billion globally and expects it to reach $164.74 billion by 2030, growing at a compound annual rate ...